51 related articles for article (PubMed ID: 29070097)
1. [In Vitro Identification and Characteristics of CD34
Zhang YH; Yang L; Wang YZ; Kong Y; Zhu HH; Qin YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1289-1294. PubMed ID: 29070097
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric analysis of CD34
Mizuta S; Iwasaki M; Bandai N; Yoshida S; Watanabe A; Takashima H; Ueshimo T; Bandai K; Fujiwara K; Hiranuma N; Koba Y; Kawata T; Tamekane A; Watanabe M
Cytometry B Clin Cytom; 2024 Jan; 106(1):35-44. PubMed ID: 37933409
[TBL] [Abstract][Full Text] [Related]
3. A CD38-directed, single-chain T-cell engager targets leukemia stem cells through IFN-γ-induced CD38 expression.
Murtadha M; Park M; Zhu Y; Caserta E; Napolitano O; Tandoh T; Moloudizargari M; Pozhitkov A; Singer M; Dona AA; Vahed H; Gonzalez A; Ly K; Ouyang C; Sanchez JF; Nigam L; Duplan A; Chowdhury A; Ghoda L; Li L; Zhang B; Krishnan A; Marcucci G; Williams JC; Pichiorri F
Blood; 2024 Apr; 143(16):1599-1615. PubMed ID: 38394668
[TBL] [Abstract][Full Text] [Related]
4. CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia.
Hosen N; Park CY; Tatsumi N; Oji Y; Sugiyama H; Gramatzki M; Krensky AM; Weissman IL
Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11008-13. PubMed ID: 17576927
[TBL] [Abstract][Full Text] [Related]
5. Prospective validation of the prognostic relevance of CD34+CD38- AML stem cell frequency in the HOVON-SAKK132 trial.
Ngai LL; Hanekamp D; Janssen F; Carbaat-Ham J; Hofland MAMA; Fayed MMHE; Kelder A; Oudshoorn-van Marsbergen L; Scholten WJ; Snel AN; Bachas C; Tettero JM; Breems DA; Fischer T; Gjertsen BT; Griškevičius L; Juliusson G; van de Loosdrecht AA; Maertens JA; Manz MG; Pabst T; Passweg JR; Porkka K; Valk PJM; Gradowska P; Löwenberg B; de Leeuw DC; Janssen JJWM; Ossenkoppele GJ; Cloos J
Blood; 2023 May; 141(21):2657-2661. PubMed ID: 36898087
[TBL] [Abstract][Full Text] [Related]
6. Flow minimal residual disease monitoring of candidate leukemic stem cells defined by the immunophenotype, CD34+CD38lowCD19+ in B-lineage childhood acute lymphoblastic leukemia.
Wilson K; Case M; Minto L; Bailey S; Bown N; Jesson J; Lawson S; Vormoor J; Irving J
Haematologica; 2010 Apr; 95(4):679-83. PubMed ID: 19951974
[TBL] [Abstract][Full Text] [Related]
7. Leveraging IFNγ/CD38 regulation to unmask and target leukemia stem cells in acute myelogenous leukemia.
Murtadha M; Park M; Zhu Y; Caserta E; Dona AA; Singer M; Vahed H; Tasndoh T; Gonzalez A; Ly K; Sanchez JF; Chowdhury A; Pozhitkov A; Ghoda L; Li L; Zhang B; Krishnan A; Marcucci G; Williams J; Pichiorri F
bioRxiv; 2023 Mar; ():. PubMed ID: 36909542
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of mitochondria induces apoptosis and reduces telomere length and activity in acute myeloid leukemia stem cells.
Valipour B; Davari S; Farahzadi R; Pourrasol S; Mehran N; Dizaji Asl K; Altaha SM; Hojjati Z; Nozad Charoudeh H
Cell Biochem Funct; 2023 Dec; 41(8):1477-1487. PubMed ID: 38014526
[TBL] [Abstract][Full Text] [Related]
9. Primary Human Leukemia Stem Cell (LSC) Isolation and Characterization.
Meriç N; Kocabaş F
Methods Mol Biol; 2024; 2736():151-161. PubMed ID: 37428345
[TBL] [Abstract][Full Text] [Related]
10. Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosis.
Farber M; Chen Y; Arnold L; Möllmann M; Boog-Whiteside E; Lin YA; Reinhardt HC; Dührsen U; Hanoun M
Sci Rep; 2021 Nov; 11(1):22062. PubMed ID: 34764342
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotypic characterization of leukemic stem cells in acute myeloid leukemia using single tube 10-colour panel by multiparametric flow cytometry: Deciphering the spectrum, complexity and immunophenotypic heterogeneity.
Das N; Panda D; Gajendra S; Gupta R; Thakral D; Kaur G; Khan A; Singh VK; Vemprala A; Bakhshi S; Seth R; Sahoo RK; Sharma A; Rai S; Prajapati VK; Singh S
Int J Lab Hematol; 2024 Mar; ():. PubMed ID: 38456256
[TBL] [Abstract][Full Text] [Related]
12. Characterization of CD34
Nollmann C; Moskorz W; Wimmenauer C; Jäger PS; Cadeddu RP; Timm J; Heinzel T; Haas R
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610998
[TBL] [Abstract][Full Text] [Related]
13. Insight into the mechanism of CD34
Venglar O; Kapustova V; Anilkumar Sithara A; Zihala D; Muronova L; Sevcikova T; Vrana J; Vdovin A; Radocha J; Krhovska P; Hrdinka M; Turjap M; Popkova T; Chyra Z; Broskevicova L; Simicek M; Koristek Z; Hajek R; Jelinek T
Br J Haematol; 2024 Apr; 204(4):1439-1449. PubMed ID: 37807708
[TBL] [Abstract][Full Text] [Related]
14. A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy.
Pei S; Shelton IT; Gillen AE; Stevens BM; Gasparetto M; Wang Y; Liu L; Liu J; Brunetti TM; Engel K; Staggs S; Showers W; Sheth AI; Amaya ML; Minhajuddin M; Winters A; Patel SB; Tolison H; Krug AE; Young TN; Schowinsky J; McMahon CM; Smith CA; Pollyea DA; Jordan CT
Cancer Discov; 2023 Sep; 13(9):2032-2049. PubMed ID: 37358260
[TBL] [Abstract][Full Text] [Related]
15. Microfluidic chip with reversible interface for noninvasive remission status monitoring and prognosis prediction of acute myeloid leukemia.
Lai Q; Song J; Zha J; Zheng H; Deng M; Liu Y; Lin W; Zhu Z; Zhang H; Xu B; Yang C
Biosens Bioelectron; 2023 Jan; 219():114803. PubMed ID: 36252315
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine-1-phosphate receptor 3 potentiates inflammatory programs in normal and leukemia stem cells to promote differentiation.
Xie SZ; Kaufmann KB; Wang W; Chan-Seng-Yue M; Gan OI; Laurenti E; Garcia-Prat L; Takayanagi SI; Ng SWK; Xu C; Zeng AGX; Jin L; McLeod J; Wagenblast E; Mitchell A; Kennedy JA; Liu Q; Boutzen H; Kleinau M; Jargstorf J; Holmes G; Zhang Y; Voisin V; Bader GD; Wang JCY; Hannun YA; Luberto C; Schroeder T; Minden MD; Dick JE
Blood Cancer Discov; 2021 Jan; 2(1):32-53. PubMed ID: 33458693
[TBL] [Abstract][Full Text] [Related]
17. Can CD34
Stolpa W; Mizia-Malarz A; Zapała M; Zwiernik B
Front Pediatr; 2023; 11():1213009. PubMed ID: 37675394
[TBL] [Abstract][Full Text] [Related]
18. Extended exposure to low doses of azacitidine induces differentiation of leukemic stem cells through activation of myeloperoxidase.
Jeyaraju DV; Alapa M; Polonskaia A; Risueño A; Subramanyam P; Anand A; Ghosh K; Kyriakopoulos C; Hemerich D; Hurren R; Wang X; Gronda M; Ahsan A; Chiu H; Thomas G; Lind EF; Menezes DL; Schimmer AD; Hagner PR; Gandhi A; Thakurta AG
Haematologica; 2024 Apr; 109(4):1082-1094. PubMed ID: 37941406
[TBL] [Abstract][Full Text] [Related]
19. Disulfiram/cytarabine eradicates a subset of acute myeloid leukemia stem cells with high aldehyde dehydrogenase expression.
Yang W; Xie J; Hou R; Chen X; Xu Z; Tan Y; Ren F; Zhang Y; Xu J; Chang J; Wang H
Leuk Res; 2020 Mar; 92():106351. PubMed ID: 32224355
[TBL] [Abstract][Full Text] [Related]
20. IFN-γ and CD38 in AML: a T-cell engagement made in heaven?
Lamble AJ; Rau RE
Blood; 2024 Apr; 143(16):1556-1557. PubMed ID: 38635257
[No Abstract] [Full Text] [Related]
[Next] [New Search]
